<DOC>
	<DOCNO>NCT00979121</DOCNO>
	<brief_summary>Objective : ass efficacy safety oral rosuvastatin patient sepsis-induced Acute Lung Injury ( ALI ) . Hypothesis : Rosuvastatin therapy improve mortality patient sepsis-induced ALI .</brief_summary>
	<brief_title>Statins Acutely Injured Lungs From Sepsis</brief_title>
	<detailed_description>Acute Lung Injury ( ALI ) Acute Respiratory Distress Syndrome ( ARDS ) involve extensive inflammation lung lead rapid respiratory failure . These condition commonly cause pneumonia , generalize infection , severe trauma lung , also less commonly cause smoke salt water inhalation , drug overdose , shock . For people , ALI/ARDS resolve without treatment , many severe case result hospitalization intensive care unit ( ICU ) , 30 % 40 % case end mortality . Current treatment ALI/ARDS include assist breathing ventilator , supportive care , management underlying cause . Upon admission ICU , Rosuvastatin placebo administer enteral feeding tube administer orally follow extubation patient able safely take oral medication . The type placement enteral feeding tube ( nasogastric , nasoenteric , PEG , orogastric , oroenteric , etc . ) ability safely take oral medication determine patient 's primary team . Study drug blind identical appear placebo . The first study drug dose ( rosuvastatin placebo ) administer within 4 hour randomization load dose 40 mg . Blood pressure , heart rate , ventilation setting , various blood factor measure treatment . Phone-based follow-up assessment occur month 6 12 ICU discharge include measurement health-related quality life ; psychological , neurocognitive , physical activity outcome ; healthcare utilization ; mortality .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Systemic inflammatory response syndrome ( SIRS ) define meet least criterion ( ) ( b ) systemic inflammatory response : 1 . White blood cell count &gt; 12,000 &lt; 4,000 &gt; 10 % band form 2 . Body temperature &gt; 38 degree Celsius ( C ) ( route ) &lt; 36 degree C ( accept core temperature ; indwell catheter , esophageal , rectal ) 3 . Heart rate ( &gt; 90 beats/min ) receive medication slow heart rate pace rhythm 2 . Suspected proven infection : Sites infection include thorax , urinary tract , abdomen , skin , sinus , central venous catheter , bacterial meningitis ( Appendix A ) . 3 . ALI define acute onset : 1 . PaO2 / FiO2 ≤ 300 ( intubate ) . If altitude &gt; 1000m , PaO2 / FiO2 ≤ 300 x ( PB/760 ) , 2 . Bilateral infiltrates consistent pulmonary edema frontal chest radiograph , 3 . Requirement positive pressure ventilation via endotracheal tube , 4 . No clinical evidence leave atrial hypertension , measure , Pulmonary Arterial Wedge Pressure ( PAOP ) less equal 18 mm Hg . If patient PAOP &gt; 18 mmHg , criterion must persist 12 hour PAOP decline ≤ 18 mmHg , still within 48hour enrollment window . `` Acute onset '' define follow : duration hypoxemia criterion ( # 1 ) chest radiograph criterion ( # 2 ) must ≤ 28 day time randomization . Opacities consider `` consistent pulmonary edema '' include patchy diffuse opacity fully explain mass , atelectasis , effusion opacity know chronic ( &gt; 28 day ) . The finding vascular redistribution , indistinct vessel , indistinct cardiac border consider `` consistent pulmonary edema '' . All ALI criterion ( 3ad ) must occur within 24 hour period . The onset ALI last ALI criterion meet . Patients must enrol within 48 hour ALI onset 7 day initiation mechanical ventilation . SIRS criterion must occur within 72 hour 24 hour ALI onset . Information determine time window criterion meet may come either Network hospital refer hospital report . 1 . No consent/inability obtain consent 2 . Age le 18 year 3 . More 7 day since initiation mechanical ventilation 4 . More 48 hour since meet ALI inclusion criterion 5 . Patient , surrogate , physician commit full support ) . 6 . Unable receive unlikely absorb enteral study drug 7 . Rosuvastatin specific exclusion Receiving statin medication within 48 hour randomization Allergy intolerance statin Physician insistence use avoidance statin current hospitalization Creatine Kinase ( CK ) , alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; 5 time upper limit normal Diagnosis hypothyroidism thyroid replacement therapy Pregnancy breast feed Receiving niacin , fenofibrate cyclosporine , gemfibrozil , atazanavir , lopinavir , ritonavir , daptomycin 8 . Severe chronic liver disease 9 . Moribund patient expect survive 24 hour 10 . Chronic respiratory failure define PaCO2 &gt; 60 mm Hg outpatient set 11 . Home mechanical ventilation ( noninvasive ventilation via tracheotomy ) except CPAP/BIPAP ( Continuous Positive Airway Pressure/BiLevel Positive Airway Pressure ) use solely sleepdisordered breathe 12 . Diffuse alveolar hemorrhage vasculitis 13 . Burns &gt; 40 % total body surface 14 . Interstitial lung disease severity sufficient require continuous home oxygen therapy 15 . Unwillingness inability utilize ARDS network 6 ml/kg Predicted Body Weight ( PBW ) ventilation protocol 16 . Cardiac disease classify NYHA ( New York Heart Association ) class IV 17 . Myocardial infarction within past 6 month 18 . Intraparenchymal Central Nervous System ( CNS ) bleed within month randomization . 19 . Temperature &gt; 40.3 C 6 hour randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>ALI</keyword>
	<keyword>Sepsis</keyword>
	<keyword>statin</keyword>
</DOC>